Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.pan.2014.06.004 http://scihub22266oqcxt.onion/10.1016/j.pan.2014.06.004 C4185152!4185152!25278311     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Pancreatology 2014 ; 14 (5): 403-8 Nephropedia Template TP {{tp|p=25278311|t=2014. ROLE OF PANCREATIC FAT IN THE OUTCOMES OF PANCREATITIS |pdf=|usr=}}{{25278311}} gab.com Text ROLE OF PANCREATIC FAT IN THE OUTCOMES OF PANCREATITIS JO: Pancreatology http://www.kidney.de/pget.php?&tw=1&pmid=25278311 #FOAvip The role of obesity in relation to various disease processes is being increasingly studied, with reports over the last several years increasingly mentioning its association with worse outcomes in acute disease. Obesity has also gained recognition as a risk factor for severe acute pancreatitis (SAP) [1?8]. The mortality in SAP may be as high as 30% and is usually attributable to multi system organ failure (MSOF) earlier in the disease, and complications of necrotizing pancreatitis later [9?11]. To date there is no specific treatment for acute pancreatitis (AP) and the management is largely expectant and supportive. Obesity in general has also been associated with poor outcomes in sepsis and other pathological states including trauma and burns [12?14]. With the role of unsaturated fatty acids (UFA) as propagators in SAP having recently come to light [15] and with the recognition of acute lipotoxicity, there is now an opportunity to explore different strategies to reduce the mortality and morbidity in SAP and potentially other disease states associated with such a pathophysiology. In this review we will discuss the role of fat and implications of the consequent acute lipotoxicity on the outcomes of acute pancreatitis in lean and obese states and during acute on chronic pancreatitis. Twit Text FOAVip ROLE OF PANCREATIC FAT IN THE OUTCOMES OF PANCREATITIS ????Pancreatology http://www.kidney.de/pget.php?&tw=1&pmid=25278311 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=25278311 #FOAvip English Wikipedia <ref>{{Cite pmid|25278311}}</ref> ROLE OF PANCREATIC FAT IN THE OUTCOMES OF PANCREATITIS #MMPMID25278311 Acharya C; Navina S; Singh VP Pancreatology 2014[Sep]; 14 (5): 403-8 PMID25278311show ga The role of obesity in relation to various disease processes is being increasingly studied, with reports over the last several years increasingly mentioning its association with worse outcomes in acute disease. Obesity has also gained recognition as a risk factor for severe acute pancreatitis (SAP) [1?8]. The mortality in SAP may be as high as 30% and is usually attributable to multi system organ failure (MSOF) earlier in the disease, and complications of necrotizing pancreatitis later [9?11]. To date there is no specific treatment for acute pancreatitis (AP) and the management is largely expectant and supportive. Obesity in general has also been associated with poor outcomes in sepsis and other pathological states including trauma and burns [12?14]. With the role of unsaturated fatty acids (UFA) as propagators in SAP having recently come to light [15] and with the recognition of acute lipotoxicity, there is now an opportunity to explore different strategies to reduce the mortality and morbidity in SAP and potentially other disease states associated with such a pathophysiology. In this review we will discuss the role of fat and implications of the consequent acute lipotoxicity on the outcomes of acute pancreatitis in lean and obese states and during acute on chronic pancreatitis. äROLE OF PANCREATIC FAT IN THE OUTCOMES OF PANCREATITIS (epmc).pdf DeepDyve Pubget Overpricing